12-Month Lobbying Summary - In-house Corporation

Return to 12-Month Lobbying Activity Search Results

AbCellera Biologics Inc. / Carl Hansen, President

Registration Summary

Active - Last Updated: 2024-04-01

Who is lobbying?

AbCellera Biologics Inc. (Address & business activities)

Carl Hansen, President

Received government funding or funding expected in current financial year

Yes

Business Relationships

AbCellera Biologics Inc. is not a subsidiary of any other parent companies.

Beneficiaries of the Lobbying Activity

AbCellera Biologics Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

What is being lobbied?

Subject Matter Details

Details Regarding the Identified Subject Matter
Subject matters	Details	Categories
Government Procurement, Health, Intellectual Property, Science and Technology, Taxation and Finance	Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products.	Grant, Contribution or Other Financial Benefit, Policies or Program

Subject matter details in previous versions

Details Regarding the Identified Subject Matter
Subject matters	Details	Categories
Subject matters were not required to be associated with subject matter details when this content was submitted	Communications regarding funding from various Government funding programs, opportunities to improve government activity (fund, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products.	Grant, Contribution or Other Financial Benefit

Subject matters in previous versions

Science and Technology

Subject matters added through a communication report:

Science and Technology
Science and Technology
Science and Technology
Science and Technology
Science and Technology
Science and Technology
Science and Technology
Science and Technology
Science and Technology
Science and Technology
Science and Technology
Science and Technology
Science and Technology
Science and Technology
Science and Technology

Who is being lobbied?

Government Institutions

Employment and Social Development Canada (ESDC)
Finance Canada (FIN)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
National Research Council (NRC)
Natural Resources Canada (NRCan)
Prime Minister's Office (PMO)

Communication techniques

Communication techniques that have been used or are expected to be used in the course of the undertaking:

Oral communication
Written communication

Who are the lobbyists?

Senior Officers whose lobbying activities represent less than 20% of their Duties

Andrew Booth, Chief Financial Officer | No public offices held
Murray McCutcheon, VP Corporate Development | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

No lobbyists added

Registration number: 945748-366216
View all registrations versions

Monthly Communication Reports

What oral and arranged communications have taken place?

What oral and arranged communications have taken place?
Date	DPOH, Position Title \| Government Institution	Subject Matters
2024-05-10	Terry Beech, Member of Parliament House of Commons	Science and Technology
2024-05-05	Maude Lavoie, Associate Assistant Deputy Minister Finance Canada (FIN)	Science and Technology
2024-04-03	Lorraine Redekop, Director General Innovation, Science and Economic Development Canada (ISED)	Science and Technology
2024-03-14	Sue Twine, Director General National Research Council (NRC)	Science and Technology
2024-03-12	Ritu Banerjee, Assistant Deputy Minister \| Director General's Office, Innovation, Science and Economic Development Canada (ISED)	Science and Technology
2024-02-14	Mitch Davies, Senior Assistant Deputy Minister \| Office of the Deputy Minister, Innovation, Science and Economic Development Canada (ISED) Susan Twine, Director General National Research Council (NRC)	Science and Technology
2024-02-08	Cody Burdett, Senior Director \| Knowledge and Econony, Finance Canada (FIN) Samuel Millar, Associate Assistant Deputy Minister \| Assistant Deputy Minister's Office, Finance Canada (FIN) Mathew Sajkunovic, Director General, Microeconomic Policy Analysis \| Economic Development Branch, Finance Canada (FIN)	Science and Technology
2024-02-08	Michael D. Chong, Member of Parliament House of Commons	Science and Technology
2024-02-08	Denis Martel, Director General \| Collaborations and Networks , Innovation, Science and Economic Development Canada (ISED) Celine Menard, Director \| Strategic Innovation Fund, Innovation, Science and Economic Development Canada (ISED)	Science and Technology
2024-02-07	Ben Chin, Senior Advisor \| Minister's Office, Prime Minister's Office (PMO)	Science and Technology
2024-02-07	Rodrigo Arancibia, Director \| Life Science Industries Directorate, Innovation, Science and Economic Development Canada (ISED) Ritu Banerjee, Assistant Deputy Minister \| Director General's Office, Innovation, Science and Economic Development Canada (ISED)	Science and Technology
2023-09-28	Chris Forbes, Deputy Minister of Finance Finance Canada (FIN)	Science and Technology
2023-09-28	Eric Costen, Associate Assistant Deputy Minister Innovation, Science and Economic Development Canada (ISED)	Science and Technology
2023-09-06	Simon Kennedy, Deputy Minister Innovation, Science and Economic Development Canada (ISED)	Science and Technology
2023-07-26	Mitch Davies, Senior Assistant Deputy Minister \| Office of the Deputy Minister, Innovation, Science and Economic Development Canada (ISED)	Science and Technology

View all monthly communication reports

Return to 12-Month Lobbying Activity Search Results

End date of the last completed financial year: 2023-12-31

List of Government Funding
Government Institution	Funding Received in Last Financial Year	Funding Expected in Current Financial Year
Strategic Innovation Fund (SIF)	$49,300,382.74	Yes

Government funding in previous versions

List of Government Funding
End date of the last completed financial year	Government Institution	Funding Received in Last Financial Year	Funding Expected in Current Financial Year
2022-12-31	Strategic Innovation Fund (SIF)	$34,637,690.00	Yes
2022-12-31	Western Economic Diversification Canada (WD)	$1,960,000.00	No

Search and menus

Language selection

12-Month Lobbying Summary - In-house Corporation

AbCellera Biologics Inc. / Carl Hansen, President

Who is lobbying?

AbCellera Biologics Inc. (Address & business activities)

Received government funding or funding expected in current financial year

Business Relationships

Beneficiaries of the Lobbying Activity

What is being lobbied?

Subject Matter Details

Subject matters in previous versions

Subject matters added through a communication report:

Who is being lobbied?

Government Institutions

Communication techniques

Who are the lobbyists?

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

What oral and arranged communications have taken place?

12-Month Lobbying Summary - In-house Corporation

AbCellera Biologics Inc. / Carl Hansen, President

AbCellera Biologics Inc. (Address & business activities)

Received government funding or funding expected in current financial year

Business Relationships

Beneficiaries of the Lobbying Activity

Subject Matter Details

Subject matters in previous versions

Subject matters added through a communication report:

Government Institutions

Communication techniques

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

AbCellera Biologics Inc. - Address & business activities